Turkish Journal of Gastroenterology
Author’s Reply

RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

1.

Department of Internal Medicine, Division of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey

2.

Department of Internal Medicine, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey

3.

Department of Dermatology, Marmara University, School of Medicine, Istanbul, Turkey

Turk J Gastroenterol 2023; 34: 310-310
DOI: 10.5152/tjg.2023.237002
Read: 188 Downloads: 43 Published: 01 March 2023

Cite this article as: Ergenç İ, Kani HT, Karabacak M, et al. RE: risk of HBV reactivation in HBsAg negative and anti-HBc IgG positive patients receiving biologic therapy. Turk J Gastroenterol. 2023;34(3):310.

Files
EISSN 2148-5607